RARRES1 and nonpapillary renal cell carcinoma: Finally, several potential compounds and druggable targets (NMU, RARRES1) were selected for low Cuscore group.<h4>Conclusion</h4>Overall, our study revealed the non-negligible role of cuproptosis in ccRCC development.